Bio Approaches South West BioApproaches Bio-Buzz - BioApproaches SW Newsletter

BioBuzz 3 / 2006

April 2006

IN THIS ISSUE

- Headline News
- Update
- Industry corner
- Events to look out for


HEADLINE NEWS  


GOVERNMENT OFFERS £80M FOR TECHNOLOGY PROJECTS

The Spring 2006 technology UK business is to get £80million next month to support technology innovation, Trade and Industry Secretary Alan Johnson announced today.

The Spring 2006 technology priority for areas relevant to Lifesciences and biotechnology include:

- Bioscience & Healthcare: Exploitation of Plant and Microbial Bioscience for Industry - £4m; Safety Biomarkers for Pharmaceutical Development - £8m

- Information & Communication Technology: Data, Scientific and Medical Visualisation for innovative products and services - £9m

More details about the Technology Programme, the Spring 06 Collaborative R&D competition, events and how to apply can be accessed through http://www.dti.gov.uk/technologyprogramme  

The key event to engage Industry is the strategy launch on 26th April, Barbican, London giving businesses the opportunity to find out more about the Key Technology strategies and how to input to the process of developing them further. The Technology Programme competition for collaborative research and development projects will also formally open for applications at this meeting.

A series of partnering events and applicant briefings will be held in May with the support of the Research Councils, Regional Development Agencies and Devolved Administrations. 

The Technology Strategy Board's Annual Report and Call to Action can be found at: http://www.dti.gov.uk/technologystrategy

- BioApproaches SW next main event (May/June 2006  Date to be announced)
Business advances through knowledge, improved presentation, and strategic recruitment
Focus: Three interactive workshops covering:

1) Knowledge management tools, recently acquired by BioApproaches SW will give you the edge on new IP and business opportunities in your fields of interest. Through one-to-one demonstrations gain market intelligence and new potentials for business development and collaborations (nationally and internationally dependent upon your need).
2) Market presentations to improve your business proposals and delivery towards greater success in your perspective markets.
3) Recruitment workshop to explore your sector specific needs to recruit non-graduates, graduate and experienced professionals. Update your understanding about how BioApproaches SW takes up the challenge to meet your needs and assembles specialist recruiters, interim managers and head-hunters to discuss your needs directly.

Contact: Jade Fulbrook-Smith T: 0117 9008250 E: jade.fulbrook-smith@bioapproaches.co.uk

- Hunter-Fleming secures a new cross-Atlantic deal worth over £7M

Bristol based Hunter-Fleming secures its next round of funding
Hunter-Fleming focuses on new treatments for degenerative disorders including Alzheimer's disease, heart attack and rheumatoid arthritis announced the completion of a £15.5 million financing, comprising a Series B round and funds to establish a strategic joint venture.
The new funds will be used to progress Hunter-Fleming's pipeline and specifically to continue the clinical development of three compounds. Patient recruitment for Phase IIa marker study of HF0220 in mild to moderate Alzheimer's disease is expected to commence in the second quarter of 2006; HF0420, positioned to address conditions including neuronal repair and spinal cord injury, will move into Phase II studies in Q2 2007 after further volunteer studies. Similarly, HF0299 in 2007 is expected to enter Phase II studies to treat neuropathic pain on completion of the remaining Phase I programme.
Hunter-Fleming also announces that is has set up a joint venture with dedicated funding to fast track the development of HF1020, a compound that embraces a novel concept for treating asthma and allergic conditions. The compound came from an extensive research programme at Bristol University 's Medical School .
Marios Fotiadis of Advent International said "We believe that HF1020 has potential as a major breakthrough in treating asthma. Early data has shown a strong mode of action and persuasive pharmacology. It's novel mode of action, via activation of one's own immune regulatory systems, represents and enormous potential opportunity in allergic disease, such as asthma and autoimmune conditions such as Rheumatoid Arthritis."
Jim Murray added: "Up to £8.6 million will be made available to finance the development of HF1020 to a stage where it will be very attractive for big pharma."

UPDATE

BioApproaches SW- AstraZeneca - Discovery Alliance and the SW Lifesciences

Feedback : AstraZeneca and SW organisations valued this visit to the region. Already BioApproaches SW has been approached by AstraZeneca for follow-up with attendant SW organisations. Feedback from the Industry was very positive and this sort of business development platform will be followed up with invitations to other senior bio-organisations especially as 'the top 20 pharmaceutical companies are becoming increasingly dependent on licensing to generate ethical sales' - Datamonitor, 2006. Bio-business profiles are being compiled in a South West promotional brochure to be used to attract further business opportunities in the US at the Bio2006 industry event (9 to 13th April).

BioApproaches SW bespoke event co-chaired with the former Welsh Development Agency (9th March) - Biobusiness KTN - MarineBio
Focus: South West organisations with a Marine focus were brought together with organisations from Wales to elaborate on West Britain's marine strengths and to discuss opportunities provided by the new National Biobusiness KTN (
www.biosciencektn.com ). The meeting has already resulted in new business opportunities between the regions.

BioApproaches SW - Knowledge Management Service - For business development and market intelligence see proposed May/June event 2006 or contact: Gugs Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.uk


INDUSTRY CORNER  

Recruitment

- The following specialists are available in the SW for employment:
Analytical Chemist * Analytical Technician * Compound Coordinator * Database Manager * Database Support Assistant *
Group Leader (High Throughput Chemistry) * High Throughput Chemist * High Throughput Technician * HR Manager *
Purification Technician * Research Chemist * Scale Up Chemist * Scientific Assistant (Compound Handling) *
Scientific Assistant (HTC) * Scientific Assistant (Laboratory Support) * Scientific Assistant (Purification) * Scientific Assistant (Scale Up) Contact: Louise Cantrill E.
Louise.Cantrill@e-penna.com

Courses.CPD.Courses

- Managing the Media and Executive Presentations - This workshop is for you if you are a senior manager In a Life Science company, will soon be speaking to investors, analysts, angles or VC's for essential funding, you are speaking to a more demanding audience and want to influence rather than just inform or you want to use the media to raise the profile of your company, market to the general public or prepare for crisis management. Event date: 8th and 9th of May 2006. Location of event: Bristol . For more information contact: Tim Tarrant at tim@shinepresentations.com

- Communication via e-mail is an overlooked area of customer service...  A poorly prepared response to an e-mail query can lead to irritation and misunderstandings.   Watermans have designed a training programme for delegates to develop a fluent, professional style of writing.  Make sure that your e-mails re-enforce your high customer service standards by investing in your team's skills. Course details can be found at www.watermans.uk.com ; to book please call Liz Perrett on 01666 825123.

- 4-6 April 2006 European Pharmaceutical spring school - Cambridge . Contact Anthony Andrews : anthony.andrews@informa.com or visit www.ibc-lifesci.com/springschool

Funds.Funding.Funds

-  GOVERNMENT OFFERS £80m FOR TECHNOLOGY PROJECTS - UK business is to get £80million next month to support technology innovation, Trade and Industry Secretary Alan Johnson announced today.see above (Headline News) for details

- SWRDA Innovation Team have information on the Grant for Research and Development.for further details please go to www.southwestrda.org.uk/newsletters/innovation-relay-centre.htm

News. News. News

- SEEDA, the South East Regional Development Agency, has an indicative total of £1.5M funding available for collaborative experimental development projects in medical imaging or medical informatics. Projects looking for support in the region of £0.5M-£1.0M (and therefore project totals of £1.0M-£5M), focusing on taking healthcare technologies to market. Projects may involve partners from anywhere in the UK , EU or overseas, with a majority of business-partner activity located in the South East region of the UK . Outline proposals are requested to be sent to janewilliams@seeda.co.uk

- The market for influenza vaccines is growing at an astonishing pace, Datamonitor predicts that by 2010 the market value for influenza vaccines will reach $3.7 billion - those research organisations wanting to develop opportunities in this region contact   Gugs Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.uk   

- With the launch of Novartis/Genentech/Tanox's Xolair in 2003, respiratory has emerged as a new therapy area for monoclonal antibody developers - those organisations considering following this market route through to commercialisation and seeking collaboration contact  Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.uk

Partnering opportunity.. Business opportunity

- BioJapan 2005 is to be held in Osaka this September and has 50 seminar sessions and 279 booth exhibits by 273 companies and governmental bodies from 17 countries/regions attracting more than 20,000 visitors. See http://expo.nikkeibp.co.jp/biojapan/2006/eng/ for further information, for our SWRDA Japanese business development partners details contact Jade Fulbrook-Smith T: 0117 9008250 E: jade.fulbrook-smith@greatwesternenterprise.co .

- A Functional Food/Nutraceutical Outward Mission to Finland/Sweden and Denmark is being arranged from 21 May to 24 May.  We are aiming to recruit 6-8 companies to take part in the mission.  Companies will need to fund their flight and accommodation costs in each of the countries.  We will arrange the seminars, one to one partnering sessions and company visits and receptions and networking dinners for the group. Contact: Caroline Hart , UK Trade & Investment, T: 01223 484 673, E: caroline.hart@uktibiotech.org.uk .

EVENTS

3 month forecast in chronological order

- 27th April 2006 9:00 -17:00. TBC - From Concept to CE Marking An Introduction to European Medical Device Regulation, Leicestershire contact: Medilink East Midlands website on www.medilinkem.com or email max@medilinkem.com
- Wednesday May 3rd (13.00 - 18.00). UK Stem Cell Partnering Event in association with SYBEN and London Regenerative Medicine Network - Full details at
www.londonbiotechnology.co.uk  
- Wednesday May 3rd - Biowednesday (18.00 - 21.00). "International Stem Cell Research" - in association with SYBEN and Regenerative Medicine Network - Full details at
www.londonbiotechnology.co.uk  
- 9th May 2006 Beer & Partners bi-annual Investment fair in London . This is the biggest of event of its kind in Europe bringing companies looking for "business angel" capital face to face directly with around 150 of our investors. For £750 B & P cannot guarantee success but can usually "engineer" between 8 and 10 meetings as a direct result of the day. If you are a company looking for equity in the £100,000 to £2million range, contact Roderick Beer on 08701 633033, e-mail
rbeer@beerandpartners.com .
- 22-24 May 2006 European Cell Line Development & Engineering - Renaissance Zurich Hotel , Switzerland , see
http://www.ibc-lifesci.com/celldev/default.asp?src=cgsig
- 14-17 May 2006. Regenerative Medicine Network - Full details at
www.londonbiotechnology.co.uk    SCIpharm 2006, EICC, Edinburgh  bringing chemical science and business together - Full details at www.scipharm.info
- 17th May 2006 POSReF Peninsula Oxidative Stress Research Forum - "Antioxidants in infants with Downs Syndrome" & "The arachidonic acid cascade meets nitric oxide metabolism" Lavender House Hotel, Ashburton. Contact
cathy.maguire@pms.ac.uk or We see PMS Event's page http://www.pms.ac.uk/pms/school/events.php
- 18th May 2006. 3rd Annual Science and Innovation 2006 - taking up the technology challenge QEII Conference Centre, London . Contact Sabrina on 0800 5429585
www.govnet.co.uk/science
- ACHEMA 2006, 15 to 19 May 2006, Frankfurt, Germany: Chemical Engineering, Environmental Protection and Biotechnology
- June 13-14th BioDevice Partnering 2006 - Building Convergent Medical Technologies, 2006 Edinburgh, Scotland - Full details at
www.ebdgroup.com/biodevice
- June 4-7, 2006 - Public Health 4th International DNA sampling conference Omni Hotel, Montreal contact: Dijana Maric [dijana.maric@srl.cam.ac.uk]
- Wednesday June 7th - Biowednesday (18.00 - 21.00) "LBN Company Showcase" (tbc) in association with London School of Economics
- June 7th-9th - BANGALORE BIO 2006 is the flagship Biotech event of India. Over the last five years, this event has emerged as the biggest congregation of India 's Biotech community and has generated tremendous interest & response both from the participants as well as the visitors. Contact: Samantha Bruce at ETNA
samantha.bruce@emtechna.net
- 27-29 June 2006. The Chinese pharmaceutical industry is growing at an astonishing rate and CPhI China is at the centre of all these exciting developments. Increasing by around 20% each year, China 's pharmaceutical market is on target to become the fifth-largest in the world by 2010. If you want to be a part of the most important pharmaceutical meeting place then come to CPhI China 2006 in Pudong, Shanghai and experience first-hand where all the major opportunities are. Please see:
http://www.cphi-china.com/ or contact Samantha Bruce at ETNA samantha.bruce@emtechna.net
- June 22 2006. 3rd Annual European Partnering and Investment Conference, London .  World renowned pharma companies looking for potential partnerships and European investors with over 60 biotechnology companies presenting. Please see conference website
www.epicbiotech.com for contact Hannah Carter at h.carter@northbankcommunications.com or on 020 7886 8150
- Wednesday July 12th - (13.00 - 19.00) UK Bio-Entrepreneur of the Year Awards (tbc) in association with UK Trade & Investment



Contact Us

For further information on any of these items, please visit our website: www.bioapproaches.co.uk or contact us directly.

Pauline Lee - Network Manager
Tel: 0117 9008250 Email: Pauline.Lee@Bioapproaches.co.uk



BioApproaches SW is funded by the South West of England Regional Development Agency to support the professional and business development of the South West of England Lifesciences and Biotechnology Industry.

South West of England - Regional Development Agency